What is needed in the markets these days is realism. Not fear or gloom, but a clear-eyed acceptance of where things actually stand. Realism...

Crisil Ratings stated that India Inc will manage the expected 0.50 percentage point rate hike. The agency also indicated that rural demand ...

Linux Laboratories has secured $70 million in equity funding from ChrysCapital and Tata Capital Healthcare Fund III. This investment involv...

Anupam Rasayan India Limited has finalised its acquisition of a controlling interest in Bliss GVS Pharma, marking a strategic expansion int...

When fear and uncertainty are the primary feelings on the street, the ability to rationally deal with negative news drops sharply. That is ...

RoboTechnik Intelligent Technology fell as much as 8.5% in its Hong Kong debut after raising HK$5.18 billion through its IPO. Weak market s...

The US-German company has acquired a land parcel in Sanand, Gujarat, for establishing its second facility in the region to capitalise on th...

Swati Khemani, Founder & CEO of Carnelian Asset Management & Advisors, believes de-rating is the “other side of alpha” and one of the most ...

Epigral is planning a target revenue of ₹5000 crore by 2030-31, aided by upcoming production scale-ups in CPVC Resin and Epichlorohyrdin (E...

Indian equity markets saw significant declines, with the NSE Nifty 50 index dropping by over 380 points. PB Fintech experienced a sharp 36%...

Shivtek Spechemi Industries is planning to expand manufacturing capabilities through new land acquisitions and expanding existing manufactu...

Zydus Lifesciences is transitioning from a traditional pharmaceutical company to a more patient-driven organization. The company plans to f...

"From 2030 and beyond, we will see strong earnings from pure discovery-led business, which is our central business, our oncology business a...

Garware Hi-Tech Films Ltd and Lubrizol have signed a memorandum of understanding for TPU technology development. This partnership aims to l...

Jefferies has retained its Buy rating on Navin Fluorine International and raised its price target to Rs 9,405, citing growth prospects in C...

As an investor, what you need to do at this point of time is this: A bit of extra work in terms of stock-picking so that you avoid anxiety ...

The Rs 550 crore public issue was priced at Rs 676 per share. The offering comprised a fresh issue of 11.83 lakh shares worth Rs 80 crore a...